MIC (Minimum Inhibitory Concentration) testing. API Development and Formulation. Perfectus Biomed Group can test microbial contamination of pharmaceuticals. GLP Compliant

Effectively determine the antimicrobial activity of your experimental products using our high-throughput, cost-effective tissue models.

Over prescription and overuse of antimicrobials have contributed to rising levels of pathogens resistant to the current arsenal of antimicrobial products. Biofilms, composed of bacteria and/or fungi that have settled on a surface and secreted a protective matrix, also contribute to antimicrobial resistance.

A critical step in the drug-development process is antimicrobial effectiveness testing. At Perfectus Biomed Group, we give you the confidence that your lead candidates will perform well in clinical trials by assessing your products in our predictive models.

Our human skin models mimic clinical outcomes without the high financial and time costs of setting up a clinical trial. Perfectus Biomed scientists are sector leaders in the customization and adaptation of In vitro and Ex vivo studies. Our data is globally recognized by regulatory bodies and can be carried out to GLP as requested.

We offer a range of standard and customized test methods including, but not limited to, MIC testing to EUCAST standards, anti-infective efficacy, sterility testing, microbial limits testing, biocompatibility testing and bacterial endotoxin testing. We support your product through regulatory processes such as New Drug Application (NDA) submissions and Pre-IND applications.